| Courtyard Healthcare Center | |
| 2400 College Ave, Goshen, Indiana 46526 | |
| (574) 533-0351 | |
| Name | Courtyard Healthcare Center |
|---|---|
| Location | 2400 College Ave, Goshen, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 186 |
| Occupancy Rate | 67.2% |
| Medicare ID (CCN) | 155689 |
| Legal Business Name | Adams County Memorial Hospital |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1154321669 |
| Organization Name | AMERICARE LIVING OF GOSHEN |
| Address | 2400 College Ave, Goshen, IN 46528 |
| Phone Number | 574-533-0351 |
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago
| NPI Number | 1164588315 |
| Organization Name | LRC MANAGEMENT LLC, DBA THE COURTYARD OF GOSHEN |
| Doing Business As | COURTYARD HEALTH CARE CENTER |
| Address | 2400 College Ave, Goshen, IN 46528 |
| Phone Number | 574-533-0351 |
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago
| NPI Number | 1609977628 |
| Organization Name | ADAMS COUNTY MEMORIAL HOSPITAL |
| Doing Business As | MAJESTIC CARE OF GOSHEN |
| Address | 2400 College Avenue, Goshen, IN 46528 |
| Phone Number | 574-533-0351 |
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago
| NPI Number | 1639479108 |
| Organization Name | COURTYARD REHABILITATION CENTER, INC |
| Address | 2400 College Ave, Goshen, IN 46528 |
| Phone Number | 574-533-0351 |
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.44 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.35 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.12 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.19 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.31 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.87 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.7 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.04 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.76 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.82 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 22.92 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.83 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.96 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.2 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.1 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.3 | 82.93 |
News Archive
A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.
"Medicare says it will cut payments to nursing homes to correct for an unintended windfall this year, and the industry is warning that quality will be compromised. Officials announced the 11 percent cut Friday, along with other changes meant to tamp down on physical therapy costs".
Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.
Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.
Munich Leukemia Laboratory, a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM and Illumina, Inc. to help build a new cognitive technology prototype that aims to help researchers improve leukemia treatment.
› Verified 3 days ago